Kentaro Hayashi - Div Resp Med, Nihon Univ

基本信息

Career Trajectory

Bio

No content for now

Research Interests

Papers共 30 篇Author StatisticsCo-AuthorSimilar Experts

By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选

Plasma Biomarkers for Afatinib Monotherapy in EGFR-mutated Non-Small Cell Lung Cancer: Novel Insights from Companion Genomics Analysis of the EXTRA Study

Cancer treatment and research communications (2025): 100952-100952

Cited0Views0WOSBibtex

Plasma Cell-Free DNA Methylation Profile Before Afatinib Treatment is Associated with Progression-Free and Overall Survival of Patients with Epidermal Growth Factor Receptor Gene Mutation-Positive Non-Small Cell Lung Cancer

Clinical Epigeneticsno. 1 (2025): 1-14

Cited0Views0WOSBibtex

Different effects of crizotinib treatment in two non-small cell lung cancer patients with SDC4::ROS1 fusion variants

Yuta Ohishi,Yoko Nakanishi,Yukari Hirotani,Atsuko Suzuki,Tomoyuki Tanino,Haruna Nishimaki-Watanabe,Hiroko Kobayashi,Fumi Nozaki,Sumie Ohni,Xiaoyan Tang,Kentaro Hayashi,Yoshiko Nakagawa,Tetsuo Shimizu,Ichiro Tsujino,Noriaki Takahashi,Yasuhiro Gon,Shinobu Masuda

THORACIC CANCERno. 1 (2024): 89-93

Cited0Views0Bibtex

Different Effects of Crizotinib Treatment in Two Non‐small Cell Lung Cancer Patients with SDC4::ROS1 Fusion Variants

Yuta Ohishi,Yoko Nakanishi,Yukari Hirotani,Atsuko Suzuki,Tomoyuki Tanino,Haruna Nishimaki‐Watanabe,Hiroko Kobayashi,Fumi Nozaki,Sumie Ohni, Xiaoyan Tang,Kentaro Hayashi,Yoshiko Nakagawa,Tetsuo Shimizu,Ichiro Tsujino,Noriaki Takahashi,Yasuhiro Gon,Shinobu Masuda

Thoracic Cancerno. 1 (2023): 89-93

Cited0Views0Bibtex

SpO2/FIO2 ratio 3 days after treatment with tocilizumab is a prognostic factor in patients with COVID-19: A retrospective cohort study

Yusuke Kurosawa,Yutaka Kozu,Kaori Soda, Yasunori Itoda,Naho Furusho,Ryosuke Ozoe,Yusuke Jinno,Masayuki Nomoto,Akifumi Hirata,Mamiko Hoshi, S. Yamada,Tsutomu Nishizawa, Kenichi Sugaya,Sotaro Shikano,Kentaro Hayashi,Hisato Hiranuma,Tetsuo Shimizu,Tadateru Takayama,Kazuo Chin,Yasuhiro Gon

Research Square (Research Square) (2023)

Cited0Views0Bibtex

Anti-synthetase Syndrome-Associated Interstitial Lung Disease Possibly Caused by Atezolizumab in a Patient with Lung Adenocarcinoma: a Case Report

Ippei Miyamoto,Tetsuo Shimizu,Ryo Kusahana,Masayuki Nomoto, Daishi Fujiwara,Tsukasa Nishizawa,Kentaro Hayashi,Yoshiko Nakagawa,Yasuhiro Gon

BMC PULMONARY MEDICINEno. 1 (2023)

Cited1Views0WOSBibtex

Different effects of crizotinib treatment in two non-small cell lung cancer patients with SDC4::ROS1 fusion variants

Thoracic cancerno. 1 (2023): 89-93

Cited0Views0WOSBibtex

Author Statistics

Co-Author

Co-Institution

D-Core

合作者
学生
导师

No result temporarily, you can search similar Scholar with the same research interest

Data Disclaimer

The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn